Caird DM - Search Results

1

Effect of treatment with Ginkgo biloba extract EGb 761 (oral) on unilateral idiopathic sudden hearing loss in a prospective randomized double-blind study of 106 outpatients.

Burschka MA, Hassan HA, Reineke T, van Bebber L, Caird DM, Mösges R. Burschka MA, et al. Among authors: caird dm. Eur Arch Otorhinolaryngol. 2001 Jul;258(5):213-9. doi: 10.1007/s004050100343. Eur Arch Otorhinolaryngol. 2001. PMID: 11548897 Clinical Trial.

2

Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR.

Schopohl J, Strasburger CJ, Caird D, Badenhoop K, Beuschlein F, Droste M, Plöckinger U, Petersenn S; German Lanreotide Study Group. Schopohl J, et al. Exp Clin Endocrinol Diabetes. 2011 Mar;119(3):156-62. doi: 10.1055/s-0030-1267244. Epub 2010 Nov 17. Exp Clin Endocrinol Diabetes. 2011. PMID: 21086246 Clinical Trial.

3

Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors.

Faiss S, Räth U, Mansmann U, Caird D, Clemens N, Riecken EO, Wiedenmann B. Faiss S, et al. Digestion. 1999 Sep-Oct;60(5):469-76. doi: 10.1159/000007693. Digestion. 1999. PMID: 10473972

4

Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?

Wohlfarth K, Sycha T, Ranoux D, Naver H, Caird D. Wohlfarth K, et al. Curr Med Res Opin. 2009 Jul;25(7):1573-84. doi: 10.1185/03007990903028203. Curr Med Res Opin. 2009. PMID: 19463043 Review.

5

Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.

Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D; German-Austrian Retrospective Study Group. Rzany B, et al. Dermatol Surg. 2007 Jan;33(1 Spec No.):S18-25. doi: 10.1111/j.1524-4725.2006.32327.x. Dermatol Surg. 2007. PMID: 17241409

6

Comparison of type a botulinum toxin products in clinical use.

Pickett A, Caird D. Pickett A, et al. J Clin Pharm Ther. 2008 Jun;33(3):327-8. doi: 10.1111/j.1365-2710.2008.00904.x. J Clin Pharm Ther. 2008. PMID: 18452421 No abstract available.

7

Comments and corrections on the REAL DOSE study.

Kingswell RS, Caird D. Kingswell RS, et al. Mov Disord. 2006 Apr;21(4):582-3; author reply 583-4. doi: 10.1002/mds.20829. Mov Disord. 2006. PMID: 16511854 No abstract available.

8

Discussion regarding botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Minimal risk of antibody formation after aesthetic treatment with type a botulinum toxin.

Pickett A, Caird D. Pickett A, et al. Facial Plast Surg Clin North Am. 2009 Nov;17(4):633-4; discussion 634-77, vii. doi: 10.1016/j.fsc.2009.07.003. Facial Plast Surg Clin North Am. 2009. PMID: 19900668

9

Binaural masking level difference effects in single units of the guinea pig inferior colliculus.

Caird DM, Palmer AR, Rees A. Caird DM, et al. Hear Res. 1991 Dec;57(1):91-106. doi: 10.1016/0378-5955(91)90078-n. Hear Res. 1991. PMID: 1774216

10

Cochlear potentials and auditory evoked potentials in the caiman (Caiman crocodilus (L.)).

Smolders JW, Caird DM, Klinke R. Smolders JW, et al. Among authors: caird dm. Electroencephalogr Clin Neurophysiol. 1990 Feb;75(2):97-104. doi: 10.1016/0013-4694(90)90157-f. Electroencephalogr Clin Neurophysiol. 1990. PMID: 1688779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results